Skip to main content
NCD 190.3 · version 1

NCD 190.3: Cytogenetic Studies

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 190.3

Benefit category
Diagnostic Tests (other)
Effective date
07/16/1998
Transmittal
Transmittal 105
Versions published
1
Manual section
190
Pathology and Laboratory, NCD Manual (Pub. 100-03) chapter 1 part 3

TL;DR

NCD 190.3 sets Medicare's national policy for cytogenetic studies under the benefit category "Diagnostic Tests (other)", effective 07/16/1998. Medicare covers these tests when they are reasonable and necessary for the diagnosis or treatment of the following conditions: It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

The term cytogenetic studies is used to describe the microscopic examination of the physical appearance of human chromosomes.

Indications and limitations of coverage

Medicare covers these tests when they are reasonable and necessary for the diagnosis or treatment of the following conditions:

• Genetic disorders (e.g., mongolism) in a fetus; (See the Medicare Benefit Policy Chapter 15, "Covered Medical and Other Health Services," §20.1)

• Failure of sexual development;

• Chronic myelogenous leukemia;

• Acute leukemias lymphoid (FAB L1-L3), myeloid (FAB M0-M7), and unclassified; or

• Mylodysplasia

Text reproduced from the CMS Medicare Coverage Database record for NCD 190.3 version 1. View the original on cms.gov.

Local policies that build on this NCD

5 active Local Coverage Determinations cite NCD 190.3 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 190.3

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 3 current articles in the Medicare Coverage Database name NCD 190.3, 3 of them with a covered ICD-10-CM list, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 190.3
ContractorArticles
Wellpoint FederalA56793, A56867, A58963

A56793: Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

89 covered ICD-10-CM codes in 3 groups; 4 procedure codes: 81450, 81451, 81455, 81456. Local policy: L37606 Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases. Check a diagnosis for 81450.

First covered codes: C92.00 Acute myeloblastic leukemia, not having achieved remission; C92.02 Acute myeloblastic leukemia, in relapse; C92.30 Myeloid sarcoma, not having achieved remission; C92.32 Myeloid sarcoma, in relapse; C92.40 Acute promyelocytic leukemia, not having achieved remission; C92.42 Acute promyelocytic leukemia, in relapse; …

A56867: Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

Billing and Coding, effective 2026-10-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

675 covered ICD-10-CM codes; 17 procedure codes: 0048U, 0244U, 0250U, 0329U, 0334U, 0379U, 0391U, 0473U, 0543U, 0696U, 81445, 81449 and 5 more. Local policy: L37810 Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms. Check a diagnosis for 0048U.

First covered codes: C00.0 Malignant neoplasm of external upper lip; C00.1 Malignant neoplasm of external lower lip; C00.2 Malignant neoplasm of external lip, unspecified; C00.3 Malignant neoplasm of upper lip, inner aspect; C00.4 Malignant neoplasm of lower lip, inner aspect; C00.5 Malignant neoplasm of lip, unspecified, inner aspect; …

A58963: Billing and Coding: Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE)

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

198 covered ICD-10-CM codes in 2 groups; 3 procedure codes: 87505, 87506, 87507. Local policy: L39226 Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE). Check a diagnosis for 87505.

First covered codes: A09 Infectious gastroenteritis and colitis, unspecified; R19.7 Diarrhea, unspecified; A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae; A00.1 Cholera due to Vibrio cholerae 01, biovar eltor; A00.9 Cholera, unspecified; A01.00 Typhoid fever, unspecified; …

Revision history

08/2026 - Transmittal 13903 issued August 07, 2026, is being rescinded and replaced by Transmittal 13923, dated August 14, 2026, to update NCD 20.4 Implantable Cardioverter Defibrillator (ICD) to include additional business requirements for Place of Service (POS) and Claim Adjustment Reason Code (CARC) and Remittance Advice Remark Code (RARC) messages. All other information remains the same. ( TN 13923 ) (CR14570)

08/2026 - The purpose of this Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations (NCDs). No policy is being changed as a result of these updates. ( TN 13903 ) (CR14570)

09/2025 - Transmittal 13400 issued September 05, 2025, is being rescinded and replaced by Transmittal 13438, dated September 30, 2025, to add a new attachment to ensure the functionality of the NCD zip URL is working properly and to update the Policy section. All other information remains the same.

The purpose of this Change Request (CR) is to provide a maintenance update of ICD-10 coding changes specific to NCDs. ( TN 13438 ) (CR14197)

08/2025 - The purpose of this Change Request (CR) is to provide a maintenance update of ICD-10 coding changes specific to NCDs. ( TN 13375 ) (CR14197)

10/2024 - The purpose of the Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations(NCDs). No policy is being changed as a result of these updates. ( TN 12903 ) (CR13818)

01/2024 - Transmittal 12350 issued November 03, 2023, is being rescinded and replaced by Transmittal 12440 dated January 3, 2024, to make changes to NCD 90.2, Next Generation Sequencing, spreadsheet to align with revisions being made to CR 13278. All other information remains the same. ( TN 12440 ) (CR13391)

11/2023 - The purpose of this Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations (NCDs). No policy is being changed as a result of these updates.( TN 12350 ) (CR13391)

10/2023 - The purpose of this Change Request (CR) is to provide a quarterly maintenance update of ICD-10 coding conversions and other coding updates specific to National Coverage Determinations (NCDs). No policy is being changed as a result of these updates. ( TN 12319 ) (CR13391)

10/2022 - Transmittal 11546, dated August 4, 2022, is being rescinded and replaced by Transmittal 11636,

dated, October 5, 2022, to remove ICD-10 dx codes added in error to NCD 150.3, business requirement 12842.4, and restore ICD-10 dx C91.92 removed in error to NCD 110.23, business requirement 12842.3. All other information remains the same. ( TN 11636 ) (CR12842)

08/2022 - The purpose of this Change Request (CR) is to provide a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. ( TN 11546 ) (CR12842)

10/2021 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received. ( TN 11083 ) (CR12482)

01/2021 - Transmittal 10515, dated December 10, 2020, is being rescinded and replaced by Transmittal 10566, dated, January 14, 2021 to remove FISS Reason Codes (RCs) 59041, 59042, 59209, and 59210 from the spreadsheet for NCD 160.18. All other information remains the same. ( TN 10566 ) (CR12027)

12/2020 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, longstanding NCD process. ( TN 10515 ) (CR12027)

10/2020 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, longstanding NCD process. ( TN 10432 ) (CR12027)

02/2020 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, longstanding NCD process. ( TN 2439 ) (CR11655)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 190.3

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 190.3

What does NCD 190.3 cover?

Medicare covers these tests when they are reasonable and necessary for the diagnosis or treatment of the following conditions: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 190.3 take effect?

The current version (1) is effective 07/16/1998, published in transmittal 105. This is the only published version.

Does a Local Coverage Determination override NCD 190.3?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.